Venture Capital Archives - Page 3 of 101

Cellino CEO Nabiha Saklayen Named EY’s Entrepreneur Of The Year 2025 for New England

June 13, 2025

Parallel Bio Raises $21 Million to Advance Human-Based Drug Discovery, Partners with Centivax on Universal Flu Vaccine

June 13, 2025

athenahealth, Humana, and Your Health Recognized for Reducing Care Gaps and Streamlining Clinician Workflows

June 12, 2025

THIS WEEK'S STORIES

BostonGene Wins GRASP Advocate Choice Award at ASCO 2025 for AI-Powered Insights into Invasive Lobular Carcinoma

June 9, 2025

GoodRx Launches Community Link to Bring Cost-Plus Pricing to Independent Pharmacies

June 9, 2025

InSilicoTrials Joins Microsoft Pegasus Program to Drive Innovation in Digital Drug Development

June 11, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Robotic Pet Startup Tombot Raises $6.1 Million to Launch Therapeutic Companion for Seniors

Parallel Bio Raises $21 Million to Advance Human-Based Drug Discovery, Partners with Centivax on Universal Flu Vaccine

Autonomize AI Secures $28 Million Series A to Advance Agentic AI in Healthcare Operations

North Chicago Biotech Firm 32 Biosciences Raises $6 Million to Advance Gut Microbiome Technologies

Allay Therapeutics Secures $57.5M in Series D Funding to Advance Post-Surgical Pain Therapy ATX101

Most Read

Robotic Pet Startup Tombot Raises $6.1 Million to Launch Therapeutic Companion for Seniors

FDA Approves Merck’s Keytruda for Perioperative Use in Certain Head and Neck Cancer Patients

Cellino CEO Nabiha Saklayen Named EY’s Entrepreneur Of The Year 2025 for New England

Astria Therapeutics Reports Strong Long-Term Results for Navenibart in Hereditary Angioedema Patients

EDITOR PICKS

Cellino CEO Nabiha Saklayen Named EY’s Entrepreneur Of The Year 2025 for New England

Parallel Bio Raises $21 Million to Advance Human-Based Drug Discovery, Partners with Centivax on Universal Flu Vaccine

athenahealth, Humana, and Your Health Recognized for Reducing Care Gaps and Streamlining Clinician Workflows

THIS WEEK'S STORIES

BostonGene Wins GRASP Advocate Choice Award at ASCO 2025 for AI-Powered Insights into Invasive Lobular Carcinoma

GoodRx Launches Community Link to Bring Cost-Plus Pricing to Independent Pharmacies

InSilicoTrials Joins Microsoft Pegasus Program to Drive Innovation in Digital Drug Development

POPULAR CATEGORY

ABOUT US

FOLLOW US